Tarsus Pharmaceuticals (TARS) announced the appointment of Katherine Goodrich, M.D., MHS, Chief Medical Officer of Humana Inc., to its Board of Directors. Published first on TheFly – the ultimate ...
Barclays analyst Balaji Prasad assigned a Buy rating to Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of $60.00. The company’s shares closed yesterday at $47.57.